These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15110741)

  • 21. Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.
    Kendrick T; Chatwin J; Dowrick C; Tylee A; Morriss R; Peveler R; Leese M; McCrone P; Harris T; Moore M; Byng R; Brown G; Barthel S; Mander H; Ring A; Kelly V; Wallace V; Gabbay M; Craig T; Mann A
    Health Technol Assess; 2009 Apr; 13(22):iii-iv, ix-xi, 1-159. PubMed ID: 19401066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls.
    Moreno FA; Parkinson D; Palmer C; Castro WL; Misiaszek J; El Khoury A; Mathé AA; Wright R; Delgado PL
    Eur Neuropsychopharmacol; 2010 Jan; 20(1):18-24. PubMed ID: 19896342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine.
    Bell C; Forshall S; Adrover M; Nash J; Hood S; Argyropoulos S; Rich A; Nutt DJ
    J Psychopharmacol; 2002 Mar; 16(1):5-14. PubMed ID: 11949771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Personality change during depression treatment: a placebo-controlled trial.
    Tang TZ; DeRubeis RJ; Hollon SD; Amsterdam J; Shelton R; Schalet B
    Arch Gen Psychiatry; 2009 Dec; 66(12):1322-30. PubMed ID: 19996037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Affective state and EEG sleep profile in response to rapid tryptophan depletion in recently recovered nonmedicated depressed individuals.
    Haynes PL; McQuaid JR; Kelsoe J; Rapaport M; Gillin JC
    J Affect Disord; 2004 Dec; 83(2-3):253-62. PubMed ID: 15555723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Turning darkness into light. A new landmark study on the treatment of adolescent depression. Comments on the TADS study.
    Apter A; Kronenberg S; Brent D
    Eur Child Adolesc Psychiatry; 2005 May; 14(3):113-6. PubMed ID: 15959656
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of acute tryptophan depletion in serotonin reuptake inhibitor-remitted patients with generalized anxiety disorder.
    Hood SD; Hince DA; Davies SJ; Argyropoulos S; Robinson H; Potokar J; Nutt DJ
    Psychopharmacology (Berl); 2010 Feb; 208(2):223-32. PubMed ID: 19936713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action.
    Delgado PL; Miller HL; Salomon RM; Licinio J; Krystal JH; Moreno FA; Heninger GR; Charney DS
    Biol Psychiatry; 1999 Jul; 46(2):212-20. PubMed ID: 10418696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral blood volume and clinical changes on the third day of placebo substitution for SSRI treatment.
    Henry ME; Kaufman MJ; Hennen J; Michelson D; Schmidt ME; Stoddard E; Vukovic AJ; Barreira PJ; Cohen BM; Renshaw PF
    Biol Psychiatry; 2003 Jan; 53(1):100-5. PubMed ID: 12513950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue.
    Ninan PT; Hassman HA; Glass SJ; McManus FC
    J Clin Psychiatry; 2004 Mar; 65(3):414-20. PubMed ID: 15096082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose of selective serotonin uptake inhibitors across pregnancy: clinical implications.
    Hostetter A; Stowe ZN; Strader JR; McLaughlin E; Llewellyn A
    Depress Anxiety; 2000; 11(2):51-7. PubMed ID: 10812529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo.
    Entsuah AR; Huang H; Thase ME
    J Clin Psychiatry; 2001 Nov; 62(11):869-77. PubMed ID: 11775046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-thyroxine augmentation of serotonergic antidepressants in female patients with refractory depression.
    Łojko D; Rybakowski JK
    J Affect Disord; 2007 Nov; 103(1-3):253-6. PubMed ID: 17289154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.
    Hilton RC; Rengasamy M; Mansoor B; He J; Mayes T; Emslie GJ; Porta G; Clarke GN; Wagner KD; Birmaher B; Keller MB; Ryan N; Shamseddeen W; Asarnow JR; Brent DA
    J Am Acad Child Adolesc Psychiatry; 2013 May; 52(5):482-92. PubMed ID: 23622849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
    Miner CM; Brown EB; Gonzales JS; Munir R
    J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid tryptophan depletion, sleep electroencephalogram, and mood in men with remitted depression on serotonin reuptake inhibitors.
    Moore P; Gillin C; Bhatti T; DeModena A; Seifritz E; Clark C; Stahl S; Rapaport M; Kelsoe J
    Arch Gen Psychiatry; 1998 Jun; 55(6):534-9. PubMed ID: 9633672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venlafaxine extended-release: a review of its use in the management of major depression.
    Wellington K; Perry CM
    CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and physiological consequences of rapid tryptophan depletion.
    Moore P; Landolt HP; Seifritz E; Clark C; Bhatti T; Kelsoe J; Rapaport M; Gillin JC
    Neuropsychopharmacology; 2000 Dec; 23(6):601-22. PubMed ID: 11063917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia.
    Hong J; Novick D; Montgomery W; Moneta MV; Dueñas H; Peng X; Haro JM
    Asia Pac Psychiatry; 2016 Mar; 8(1):51-9. PubMed ID: 25808275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.